Evidence map›Paper›PMID 33030615›Full record

ArticleEJNMMI research2020

Brain SPECT perfusion and PET metabolism as discordant biomarkers in major depressive disorder.

Maud Tastevin, Laurent Boyer, Theo Korchia, Guillaume Fond, Christophe Lançon, Raphaëlle Richieri, Eric Guedj

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. EANM perspectives for CZT SPECT in brain applications.European journal of nuclear medicine and molecular imaging · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Maud TastevinDepartment of Psychiatry, Sainte Marguerite University Hospital, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
Laurent BoyerCEReSS-Health Service Research and Quality of Life Centre, Aix Marseille University, Marseille, France.
Theo KorchiaDepartment of Psychiatry, Sainte Marguerite University Hospital, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
Guillaume FondDepartment of Psychiatry, Sainte Marguerite University Hospital, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
Christophe LançonDepartment of Psychiatry, Sainte Marguerite University Hospital, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
Raphaëlle RichieriDepartment of Psychiatry, Sainte Marguerite University Hospital, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
Eric GuedjNuclear Medicine Department, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Aix Marseille University, Marseille, France. eric.guedj@ap-hm.fr.ORCID http://orcid.org/0000-0003-1912-6132
Aix-Marseille Université · FRAssistance Publique Hôpitaux de Marseille · FRCentre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche ANR-11-IDEX-0001-02APHM AORC junior 2014
6 · The paper itself

Abstract

backgroundBrain SPECT perfusion and PET metabolism have been, most often interchangeably, proposed to study the underlying pathological process in major depressive disorder (MDD). The objective of this study was to specify similarities and inconsistencies between these two biomarkers according to global characteristics of the disease. We conducted a retrospective study in 16 patients suffering from treatment-resistant MDD who underwent, during the same current episode, a cerebral perfusion SPECT with

resultsNo significant correlations were found between brain metabolism and either the number of depressive episodes or the duration of the disease, even at an uncorrected p-voxel < 0.005. On the other hand, the increased number of depressive episodes was correlated with decreased perfusion of the right middle frontal cortex, the right anterior cingulum cortex, the right insula, the right medial temporal cortex and the left precuneus. The increased depression duration was correlated with decreased perfusion of the right anterior cingulum cortex.

conclusionsThis preliminary study demonstrates more significant results with brain perfusion compared with glucose metabolism in treatment-resistant MDD, highlighting the value of brain SPECT despite less favourable instrumentation detection compared to PET.

Indexed as

BiomarkerMajor depressive disorderPETSPECTTreatment-resistant depression

Identifiers

PMID33030615
PMCPMC7544792
OpenAlexW3092621120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.